 Carcinoma, Papillary
"Carcinoma, Papillary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
| Descriptor ID |
D002291
|
| MeSH Number(s) |
C04.557.470.200.360 C04.557.470.700.360
|
| Concept/Terms |
Carcinoma, Papillary- Carcinoma, Papillary
- Carcinomas, Papillary
- Papillary Carcinoma
- Papillary Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Papillary".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Papillary".
This graph shows the total number of publications written about "Carcinoma, Papillary" by people in this website by year, and whether "Carcinoma, Papillary" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 1 | 1 | | 1984 | 1 | 0 | 1 | | 1985 | 1 | 0 | 1 | | 1990 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1994 | 2 | 1 | 3 | | 1995 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 2 | 1 | 3 | | 2003 | 1 | 1 | 2 | | 2004 | 2 | 0 | 2 | | 2005 | 3 | 0 | 3 | | 2006 | 2 | 1 | 3 | | 2007 | 5 | 0 | 5 | | 2008 | 1 | 2 | 3 | | 2009 | 6 | 1 | 7 | | 2010 | 2 | 1 | 3 | | 2011 | 3 | 4 | 7 | | 2012 | 2 | 3 | 5 | | 2013 | 3 | 3 | 6 | | 2014 | 4 | 5 | 9 | | 2015 | 2 | 5 | 7 | | 2016 | 7 | 2 | 9 | | 2017 | 7 | 0 | 7 | | 2018 | 5 | 0 | 5 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Papillary" by people in Profiles.
-
Holoubek SA, Yan H, Kuchta KM, Winchester DJ, Moo-Young TA, Prinz RA. Trends in nonoperative management of papillary thyroid microcarcinoma. J Surg Oncol. 2020 May; 121(6):952-957.
-
Holoubek SA, Yan H, Khokar AH, Kuchta KM, Winchester DJ, Prinz RA, Moo-Young TA. Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival. Surgery. 2020 01; 167(1):19-27.
-
Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Hulsbergen-van de Kaa CA, Bruins HM, Daneshmand S. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Urol Oncol. 2019 01; 37(1):48-56.
-
Yan H, Winchester DJ, Prinz RA, Wang CH, Nakazato Y, Moo-Young TA. Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2018 Oct; 25(11):3193-3199.
-
Johnson DN, Furtado LV, Long BC, Zhen CJ, Wurst M, Mujacic I, Kadri S, Segal JP, Antic T, Cipriani NA. Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. Arch Pathol Lab Med. 2018 07; 142(7):838-850.
-
Cracolici V, Mujacic I, Kadri S, Alikhan M, Niu N, Segal JP, Rosen LE, Sarne DH, Morgan A, Desouky S, Cipriani NA. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures. Endocr Pathol. 2018 Mar; 29(1):9-14.
-
Rajjoub SR, Yan H, Calcatera NA, Kuchta K, Wang CE, Lutfi W, Moo-Young TA, Winchester DJ, Prinz RA. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers. Surgery. 2018 05; 163(5):1134-1143.
-
Huang H, Rusiecki J, Udelsman R, Zhang Y. TSH, Thyroid Hormone, and PTC-Response. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):228-229.
-
Calcatera NA, Lutfi W, Suman P, Suss NR, Wang CH, Prinz RA, Winchester DJ, Moo-Young TA. CONCORDANCE OF PRE-OPERATIVE CLINICAL STAGE WITH PATHOLOGIC STAGE IN PATIENTS =45 YEARS OLD WITH WELL-DIFFERENTIATED THYROID CANCER. Endocr Pract. 2018 Jan; 24(1):27-32.
-
Dorff TB, Longmate JA, Pal SK, Stadler WM, Fishman MN, Vaishampayan UN, Rao A, Pinksi JK, Hu JS, Quinn DI, Lara PN. Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Cancer. 2017 Dec 01; 123(23):4566-4573.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|